Effect of tanshinone II A on expression of myocardial NF-κB in rats with pressure overload
Cai Hu
Abstract
Cai Hu
Abstract
Objective To observe the effect of tanshinone ⅡA( Tan Ⅱ A) on expression of myocardial NF-κB in rats with pressure overload,and to explore its protective effects on myocardial fibrosis. Methods The pressure overload myocardial fibrosis models were established by abdominal aorta constriction in Sprague-Dawley( SD) rats,these rats were randomly divided into four groups: sham- operation group,model group,Tan Ⅱ A group( 20mg·kg- 1·d- 1) and positive control group( captopril 100mg·kg- 1·d- 1),with 8 rats in each group. 4 weeks after the operation,the animal models were successfully established,then the rats were given drugs,with a course of 4 weeks. After 8 weeks,left ventricular mass index, myocardial tissue pathological changes,myocardial hydroxyproline content,myocardial NF-κB p65 expression were detected in rats of the four groups. Results As compared with those in sham- operation group,cardiac mass index and left ventricular mass index were significantly increased in model group( P 0. 01); as compared with those in model group,these indexes were obviously decreased in Tan Ⅱ A group( P 0. 01). As compared with that in sham- operation group,myocardial hydroxyproline content was significantly increased in model group( P 0. 01),however,as compared with that in model group,myocardial hydroxyproline content was obviously decreased in Tan Ⅱ A group( P 0. 01). As compared with those in sham- operation group,NF-κB p65 protein expression levels in myocardial tissues were significantly increased in model group( P 0. 01),however,as compared with those in model group,which were significantly decreased in Tan Ⅱ A group( P 0. 01). Conclusion Tan Ⅱ A can inhibit cardiac hypertrophy,relieve myocardial fibrosis,and the effect may be related to down- regulation of the expression of NF-κB.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of tanshinone ⅡA( Tan Ⅱ A) on expression of myocardial NF-κB in rats with pressure overload,and to explore its protective effects on myocardial fibrosis. Methods The pressure overload myocardial fibrosis models were established by abdominal aorta constriction in Sprague-Dawley( SD) rats,these rats were randomly divided into four groups: sham- operation group,model group,Tan Ⅱ A group( 20mg·kg- 1·d- 1) and positive control group( captopril 100mg·kg- 1·d- 1),with 8 rats in each group. 4 weeks after the operation,the animal models were successfully established,then the rats were given drugs,with a course of 4 weeks. After 8 weeks,left ventricular mass index, myocardial tissue pathological changes,myocardial hydroxyproline content,myocardial NF-κB p65 expression were detected in rats of the four groups. Results As compared with those in sham- operation group,cardiac mass index and left ventricular mass index were significantly increased in model group( P 0. 01); as compared with those in model group,these indexes were obviously decreased in Tan Ⅱ A group( P 0. 01). As compared with that in sham- operation group,myocardial hydroxyproline content was significantly increased in model group( P 0. 01),however,as compared with that in model group,myocardial hydroxyproline content was obviously decreased in Tan Ⅱ A group( P 0. 01). As compared with those in sham- operation group,NF-κB p65 protein expression levels in myocardial tissues were significantly increased in model group( P 0. 01),however,as compared with those in model group,which were significantly decreased in Tan Ⅱ A group( P 0. 01). Conclusion Tan Ⅱ A can inhibit cardiac hypertrophy,relieve myocardial fibrosis,and the effect may be related to down- regulation of the expression of NF-κB.
Key concepts: Medicine, Hydroxyproline, Myocardial fibrosis, Pressure overload, Captopril, Internal medicine, Fibrosis, Ventricle